Life Science Platform: Digitalization for the Pharmaceutical Industry

What a lot of head shaking we had during the Corona period: On the one hand because of the frosty atmosphere, on the other because data and infection statuses still had to be transmitted by fax. Digitalization has made rapid progress in the meantime, but in many Life science and pharmaceutical companies production figures or quality data are still recorded or transferred manually, double and triple checked or manually merged in Excel. Many companies would like to have a modern, integrated IT structure. In reality, however, grown systems, isolated solutions and rigid data silos prevent progress. This is reminiscent of the coronavirus pandemic: back then, fax was the only quick solution - and a symptom of the lack of digital infrastructure. It is precisely this dependence on outdated technologies that needs to be avoided today.

Pharmaceutical and life science companies need a powerful digital infrastructure. This should consistently capture enormous amounts of data from laboratories, production lines, and supply chains, assign it once, structure it cleanly in real-time, and make it usable. In the highly regulated healthcare market, the solution must always be secure, stable, and scalable. The information must be as simple, fast and, above all, trustworthy as possible. This also applies particularly to the transformation phase between the individual expansion stages on the path to Pharma 2035.

This is the only way C-level and management staff at life science companies can make informed decisions and control processes reliably. To achieve this, data from the areas of research & development, production, quality, and supply chain must flow seamlessly into a single, new platform. Such a platform solution must fulfill several essential core functions to ensure consistently high data quality and efficient control.

Highly regulated production environments require a deep understanding of GMP and GLP requirements (e.g., CSV and device validation), LIMS (laboratory information management systems), as well as documentation obligations and pharma audit readiness. This is precisely where the new Life Science Platform from Arvato Systems comes in. As a modular digital platform, it breaks down widely distributed data islands and silos, harmonizes data streams, and creates a uniform, integrated, and audit-proof basis. This not only enables well-founded decisions and statements to be made throughout the value chain, but also allows the company to achieve its goals.

The Life Science Platform is the culmination of our DNA, which encompasses IT, data, and AI expertise, as well as in-depth knowledge of the pharmaceutical, biotechnology, medical technology, and healthcare markets. In addition to our IT solutions, we support our customers throughout the entire digital transformation process. As we provide all services from a single source, this results in significantly better and faster outcomes.

Tools for serialization, process management, predictive maintenance, and advanced analytics form the foundation of our Life Science Platform. Another building block is our comprehensive integration, data, and AI portfolio, enhanced by our consulting team for transformation support.

For pharmaceutical companies, these four modules are particularly relevant:

• CSDB for central serialization, event, and tracking data,
• Task Manager for digitally managed, audit-proof processes,
• PRECTAVI for advanced analytics and predictive maintenance
• Tool Manager for validity and traceability in the device ecosystem.

In addition, the Life Science Platform ensures the highest level of data integration currently available in the healthcare sector thanks to its interface management.

For many managers, the question now arises: How secure is a platform that intervenes so deeply in core processes? But this is precisely why our Life Science Platform was developed in the first place. It integrates seamlessly, reduces costs, and offers competitive advantages:

• Hosting models as required: cloud-capable, but also on-premise compatible, including future-oriented offerings such as Sovereign Cloud, which meets the advantages of the cloud (security, scalability, performance) even under the highest compliance requirements
• Single sign-on and role models: strict authorization concept along the entire organizational structure
• Designed from the ground up for validation friendliness
  • Solutions are GxP-compliant according to GAMP5
  • CSV and audit friendliness taken into account in consultation with the industry
• State-of-the-art integration and structuring of all data
• AI-supported analyses: from reactive action to predictive control
• Consistent traceability and audit readiness: every action is documented - who did what, when and with what rights.

At the same time, pharmaceutical and life science companies achieve a level of security that is comparable to classic on-premise solutions and also benefit from a more modern, scalable, and future-proof IT architecture.

For top management and division heads, another focus is crucial: where are we today, why and how is our business developing?

The Life Science Platform provides a consolidated real-time overview for these requirements. Here you can see at a glance:

• Order situation and throughput times,
• Utilization of lines, labs, and resource deployment,
• Disruptions and deviations, including their causes,
• Quality and compliance KPIs along the value chain.

"At the touch of a button", management and lines receive the current status - including drill-down to batch or equipment level. The advantage: no more laboriously compiling data from different systems and preparing it in presentations. This makes management discussions faster, decisions more informed, and growth targets much more realistically achievable.

As a neutral and integrated solution provider, Arvato Systems has always focused on the multi-cloud approach. This is the only way we can provide independent advice and work with you to develop the best IT infrastructure with the best application strategy, tailored to your business objectives.

We achieve this because we understand the regulated life sciences and, in particular, the pharmaceutical market from the ground up, and develop IT, data, and application strategies that ensure a perfect system with the highest possible usability.

Our offer: We guide you through your digital maturity assessment, providing clarity on future interactions between IT, AI, and business strategy. In doing so, we preserve your business continuity, minimize risks, and develop a realistic roadmap for the entire transformation process, aligning with your business goals, stakeholder needs, and your path to Pharma 2035.